Dermal Fillers Market

Dermal fillers market to exhibit dynamic growth during the forecast period.

The global dermal fillers market is growing efficiently, expected to grow at a CAGR of 6.6%. Globally, growing minimally invasive cosmetic procedures has significantly increased the revenue of dermal fillers. Innovative application launches, along with raised demand for medical aesthetics and promising pipeline products in the aesthetics industry, are factors driving the overall growth of the dermal fillers market globally. The increasing commonness of imbalanced diet, stress, and insomnia among individuals will further spur revenue growth during the forecast period.

Market Synopsis

Biodegradable segment is expected to register higher growth by the end of 2027.

Dermal fillers can be both non-biodegradable and biodegradable (natural). The use of natural products is on the rise on a global scale, mainly utilized for wrinkles and sagging of the skin. These products are applied through tiny facial injections, also utilized in the form of non-invasive procedures to rejuvenate skin by removing wrinkles and augmenting lips and scars by replacing the lost skin. The growing trend of consuming anti-aging treatments and overall demand to look younger, majorly in the female population, are major factors driving the market growth. Additionally, rising facial and skin-related surgeries performed in the male population, along with the usage of branded products in developing nations, will enhance the overall growth of the market.

Hyaluronic Acid segment is expected to register higher growth by the end of 2027.

In 2018, hyaluronic acids generated the maximum revenue share in the market and will expand at a healthy CAGR during the forecasted timeline. In 2017, as per the statistics by the International Society of Aesthetic Plastic Surgery, internationally, more than 3.2 million hyaluronic acid dermal filler procedures were performed annually. Increasing skin care treatments and minimally invasive surgeries are important factors driving the global market. More than 90% of injectable facial surgeries are performed on females; the utilization of hyaluronic acid on a major scale in overall dermatology procedures will drive the demand on a global scale. Additionally, new technology advancements and the availability of absorbable products, polymers & particles, collagen, and other materials will propel the growth of the market.

Increasing population, expansion of dermatology clinics, Spas and the presence of top players hold the U.S. in a dominant position.

In 2018, the U.S. generated the maximum revenue share in the dermal fillers market due to an increase in the expansion of branded dermal fillers, raising awareness about newer minimally invasive procedures at low cost. Increasing utilization of facial injections and branded synthetic products in dermatology clinics and Spas will drive growth in the near future. The overall growth of the aesthetic fillers, along with demand for the ever-expanding range of hyaluronic acid dermal fillers in the Asia Pacific and Western Europe, will further spur revenue growth in the global market. The single-phase hyaluronic acid dermal fillers will boost the demand, and major applications for acne treatment, wrinkle removal, rhinoplasty, lip augmentation, and others will further spur revenue growth on a global scale.

Increased research and development with strong product pipelines in the developed regions

Major players in the dermal fillers market are Allergan plc, Nestle Skin Health (Galderma), Merz Pharma GmbH & Co. KGaA, Advanced Aesthetics Technologies, Inc. Suneva Medical, AQTIS Medical, Teoxane Laboratories, Bio ha Laboratories, Dr. Korman Laboratories Ltd., Laboratoires Vivacy, SCULPT Luxury Dermal Fillers LTD, Prollenium Medical Technologies and others. Major manufacturers are developing natural products with enhanced applications for age groups. Partnerships, acquisitions, and enhanced R&D will boost the expansion of the dermal fillers market in developing countries in the near future.

Historical & Forecast Period 

This study report represents an analysis of each segment from 2017 to 2027, considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.

Market Segmentation 

ATTRIBUTE DETAILS

Research Period  2017-2027

The base Year 2018

Forecast Period  2019-2027

Historical Year  2017

Unit  USD Million

Segmentation Product Type (2017–2027; US$ Mn)

• Biodegradable
• Non-Biodegradable

Material (2017–2027; US$ Mn)

• Hyaluronic Acid
• Poly-l-Lactic Acid
• Calcium Hydroxylapatite
• PMMA
• Others(Polyalkylimide)

Application (2017–2027; US$ Mn)

• Facial Line Correction
• Lip Enhancement
• Butt enhancement
• Knee Rejuvenation
• Others (Neck Wrinkle, Earlobe Rejuvenation, Breast Rejuvenation)

Geography (2017–2027; US$ Mn)

• North America (U.S., Canada)
• Europe (U.K., Germany, Rest of Europe)
• Asia Pacific (Japan, China, Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa (GCC, Rest of Middle East & Africa)

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better market understanding of the overall dermal fillers market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolio, and business strengths.

Key questions answered in this report.

• What are the current market trends and dynamics in the dermal fillers market and valuable opportunities for emerging players?
• Which segment accounts for the fastest CAGR during the forecast period?
• Which product type segment holds a larger market share and why?
• Are low and middle-income economies investing in the dermal fillers market?
• What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global DF Market Portraiture
2.2. Global DF Market, By Product Type, 2018 (US$ Mn)
2.3. Global DF Market, By Material, 2018 (US$ Mn)
2.4. Global DF Market, By Application, 2018 (US$ Mn)
2.5. Global DF Market, by Geography, 2018 vs. 2027 (Value %)

Chapter 3. Global Dermal Fillers (DF) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. DF Market Technologies: Future Trends
3.3. Current Scenario: New Product Launches, Increasing Popularity of Non-Invasive Cosmetic Treatments
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2018
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2018

Chapter 4. Global Dermal Fillers (DF) Market, by Product Type, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Biodegradable
4.3. Non-Biodegradable

Chapter 5. Global Dermal Fillers (DF) Market, by Material, 2017 – 2027 (US$ Mn)
5.1. Overview
5.2. Hyaluronic Acid
5.3. Poly-l-Lactic Acid
5.4. Calcium Hydroxylapatite
5.5. PMMA
5.6. Others (Polyalkylimide)

Chapter 6. Global Dermal Fillers (DF) Market, By Application, 2017 – 2027 (US$)
6.1. Overview
6.2. Facial Line Correction
6.3. Lip Enhancement
6.4. Butt enhancement
6.5. Knee Rejuvenation
6.6. Others (Neck Wrinkle, Earlobe Rejuvenation, Breast Rejuvenation)

Chapter 7. Global Dermal Fillers (DF) Market, by Geography, 2017 – 2027 (US$ Mn)
7.1. Overview
7.2. North America DF Market Analysis, 2017 – 2027
7.2.1. North America DF Market, By Product Type, 2017 – 2027 (US$ Mn)
7.2.2. North America DF Market, By Material, 2017 – 2027 (US$ Mn)
7.2.3. North America DF Market, By Application, 2017 – 2027 (US$ Mn)
7.2.4. North America DF Market, by Country, 2017 – 2027 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe DF Market Analysis, 2017 – 2027
7.3.1. Europe DF Market, By Product Type, 2017 – 2027 (US$ Mn)
7.3.2. Europe DF Market, By Material, 2017 – 2027 (US$ Mn)
7.3.3. Europe DF Market, By Application, 2017 – 2027 (US$ Mn)
7.3.4. Europe DF Market, by Country, 2017 – 2027 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific DF Market Analysis, 2017 – 2027
7.4.1. Asia Pacific DF Market, By Product Type, 2017 – 2027 (US$ Mn)
7.4.2. Asia Pacific DF Market, By Material, 2017 – 2027 (US$ Mn)
7.4.3. Asia Pacific DF Market, By Application, 2017 – 2027 (US$ Mn)
7.4.4. Asia Pacific DF Market, by Country, 2017 – 2027 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America DF Market Analysis, 2017 – 2027
7.5.1. Latin America DF Market, By Product Type, 2017 – 2027 (US$ Mn)
7.5.2. Latin America DF Market, By Material, 2017 – 2027 (US$ Mn)
7.5.3. Latin America DF Market, By Application, 2017 – 2027 (US$ Mn)
7.5.4. Latin America DF Market, by Country, 2017 – 2027 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) DF Market Analysis, 2017 – 2027
7.6.1. MEA DF Market, by Product Type, 2017 – 2027 (US$ Mn)
7.6.2. MEA DF Market, by Material, 2017 – 2027 (US$ Mn)
7.6.3. MEA DF Market, By Application, 2017 – 2027 (US$ Mn)
7.6.4. MEA DF Market, by Region, 2017 – 2027 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Allergan plc
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Nestle Skin Health (Galderma)
8.3. Merz Pharma GmbH & Co. KGaA
8.4. Advanced Aesthetics Technologies, Inc.
8.5. Suneva Medical
8.6. AQTIS Medical
8.7. Teoxane Laboratories
8.8. Bioha Laboratories
8.9. Dr. Korman Laboratories Ltd.
8.10. Laboratoires Vivacy
8.11. SCULPT Luxury DF LTD
8.12. Prollenium Medical Technologies

List of Figures

FIG. 1 Global Dermal Fillers (DF) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global DF Market Segmentation
FIG. 4 Global DF Market, by Product Type, 2017 (US$ Mn)
FIG. 5 Global DF Market, by Material, 2017 (US$ Mn)
FIG. 6 Global DF Market, by Application, 2017 (US$ Mn)
FIG. 7 Global DF Market, by Geography, 2017 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Global Market Positioning of Key DF Market Manufacturers, 2018
FIG. 10 Global Biodegradable Dermal Filler Market, 2017–2027 (US$ Mn)
FIG. 11 Global Non-Biodegradable Dermal Filler Market, 2017–2027 (US$ Mn)
FIG. 12 Global Hyaluronic Acid Dermal Filler Market, 2017–2027 (US$ Mn)
FIG. 13 Global Poly-l-Lactic Acid Dermal Filler Market, 2017–2027 (US$ Mn)
FIG. 14 Global Calcium Hydroxylapatite Dermal Filler Market, 2017–2027 (US$ Mn)
FIG. 15 Global PMMA Dermal Filler Market, 2017–2027 (US$ Mn)
FIG. 16 Global Facial Line Correction DF Market, 2017–2027 (US$ Mn)
FIG. 17 Global Lip Enhancement DF Market, 2017–2027 (US$ Mn)
FIG. 18 Global Butt Enhancement DF Market, 2017–2027 (US$ Mn)
FIG. 19 Global Knee Rejuvenation DF Market, 2017–2027 (US$ Mn)
FIG. 20 Global Others (Neck Wrinkle, Earlobe Rejuvenation, Breast Rejuvenation) Market, 2017–2027 (US$ Mn)
FIG. 21 U.S. DF Market, 2017–2027 (US$ Mn)
FIG. 22 Canada DF Market, 2017–2027 (US$ Mn)
FIG. 23 U.K. DF Market, 2017–2027 (US$ Mn)
FIG. 24 Germany DF Market, 2017–2027 (US$ Mn)
FIG. 25 Rest of Europe DF Market, 2017–2027 (US$ Mn)
FIG. 26 Japan DF Market, 2017–2027 (US$ Mn)
FIG. 27 China DF Market, 2017–2027 (US$ Mn)
FIG. 28 Rest of Asia Pacific DF Market, 2017–2027 (US$ Mn)
FIG. 29 Brazil DF Market, 2017–2027 (US$ Mn)
FIG. 30 Mexico DF Market, 2017–2027 (US$ Mn)
FIG. 31 Rest of Latin America DF Market, 2017–2027 (US$ Mn)
FIG. 32 GCC DF Market, 2017–2027 (US$ Mn)
FIG. 33 Rest of Middle East & Africa DF Market, 2017–2027 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Dermal Fillers (DF) Market
TABLE 2 Global DF Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 3 Global DF Market, by Material, 2017–2027 (US$ Mn)
TABLE 4 Global DF Market, by Application, 2017–2027 (US$ Mn)
TABLE 5 Global DF Market, by Geography, 2017–2027 (US$ Mn)
TABLE 6 North America DF Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 7 North America DF Market, by Material, 2017–2027 (US$ Mn)
TABLE 8 North America DF Market, by Application, 2017–2027 (US$ Mn)
TABLE 9 North America DF Market, by Country, 2017–2027 (US$ Mn)
TABLE 10 Europe DF Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 11 Europe DF Market, by Material, 2017–2027 (US$ Mn)
TABLE 12 Europe DF Market, by Application, 2017–2027 (US$ Mn)
TABLE 13 Europe DF Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 14 Latin America DF Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 15 Latin America DF Market, by Material, 2017–2027 (US$ Mn)
TABLE 16 Latin America DF Market, by Application, 2017–2027 (US$ Mn)
TABLE 17 Latin America DF Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 18 Asia Pacific DF Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 19 Asia Pacific DF Market, by Material, 2017–2027 (US$ Mn)
TABLE 20 Asia Pacific DF Market, by Application, 2017–2027 (US$ Mn)
TABLE 21 Asia Pacific DF Market, by Country/Region, 2017–2027 (US$ Mn)
TABLE 22 Middle East & Africa DF Market, by Product Type, 2017–2027 (US$ Mn)
TABLE 23 Middle East & Africa DF Market, by Material, 2017–2027 (US$ Mn)
TABLE 24 Middle East & Africa DF Market, by Application, 2017–2027 (US$ Mn)
TABLE 25 Middle East & Africa DF Market, by Region, 2017–2027 (US$ Mn)
TABLE 26 Allergan plc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Nestle Skin Health (Galderma).: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Merz Pharma GmbH & Co. KGaA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Advanced Aesthetics Technologies, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Suneva Medical: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 AQTIS Medical: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Teoxane Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Bioha Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Dr. Korman Laboratories Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Laboratoires Vivacy: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 36 SCULPT Luxury DF LTD: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 37 Prollenium Medical Technologies: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)